AbbVie (NYSE:ABBV) reported third quarter earnings that beat analysts' expectations on Friday and revenue that topped forecasts.
The firm reported earnings per share of $2.33 on revenue of $8.48B. Analysts polled by anticipated EPS of $2.3 on revenue of $8.38B. That compared to EPS of $2.14 on revenue of $8.24B in the same period a year earlier. The company had reported EPS of $2.26 on revenue of $8.26B in the previous quarter.
AbbVie shares lost 0.69% to trade at $79.00 in pre-market trade following the report.
AbbVie follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Merck&Co earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.51 on revenue of $12.4B. analysts expected EPS of $1.24 on revenue of $11.65B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
